SCHEMBL4929633

SCHEMBL4929633

O=C(O)CNC(=O)c1cc(Br)c(OCc2cc(NCC3CC3)cc(C(F)(F)F)c2)c(Br)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.41
THRB P10828 2/20 0.41
CRHR1 P34998 6/20 0.39
KCNH2 Q12809 2/20 0.37
CACNA1I Q9P0X4 2/20 0.37
LIPC P11150 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
MCHR1 Q99705 3/20 0.35
RHOC P08134 1/20 0.35
RHOA P61586 1/20 0.35
CCR2 P41597 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922986 0.91 CRHR1 (0.43) CRHR1KCNH2CACNA1ILIPCLIPG
SCHEMBL5718189 0.88 THRA (0.46) THRATHRBCRHR1KCNH2CACNA1I
SCHEMBL4929473 0.88 THRA (0.36) THRATHRBCRHR1KCNH2
SCHEMBL5718022 0.87 CRHR1 (0.46) THRBCRHR1KCNH2CACNA1ILIPC
SCHEMBL4926195 0.87 CACNA1I (0.39) THRATHRBCRHR1KCNH2CACNA1I
SCHEMBL4346172 0.87 THRA (0.47) THRATHRBRHOCRHOAMRGPRX4
SCHEMBL4934084 0.86 THRA (0.39) THRATHRBKCNH2CACNA1I
SCHEMBL4929184 0.85 THRB (0.47) THRATHRBCRHR1LIPCLIPG
SCHEMBL4929949 0.85 THRA (0.41) THRATHRBMCHR1RHOCRHOA
SCHEMBL4924564 0.84 THRA (0.45) THRATHRBRHOCRHOAMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885CRHR1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.